Loading clinical trials...
Loading clinical trials...
Epidemiological Study to Evaluate the Prevalence of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic NSCLC (Stage IIIB/IV Non-small Cell Lung Cancer)
Conditions
Locations
24
Spain
Research Site
Santiago de Compostela, A Coruna, Spain
Research Site
Albacete, Albacete, Spain
Research Site
Alicante, Alicante, Spain
Research Site
Elche, Alicante, Spain
Research Site
Barcelona, Barcelona, Spain
Research Site
Cáceres, Caceres, Spain
Start Date
March 1, 2010
Primary Completion Date
August 1, 2010
Completion Date
February 1, 2011
Last Updated
March 16, 2011
NCT06066138
NCT07485114
NCT05098132
NCT06284317
NCT06731413
NCT06687369
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions